ContentSproute

Finance

Karnataka delegation meets Renesas in Japan on plans to expand Bengaluru R&D presence

M B Patil, Minister for Large and Medium Industries & Infrastructure Development, Government of Karnataka | Photo Credit: SPECIAL ARRANGEMENT M B Patil, the Minister for Large and Medium Industries & Infrastructure Development, Government of Karnataka, met with senior executives of Renesas Electronics Corporation, a premier supplier of advanced semiconductor solutions, at the company’s headquarters

Karnataka delegation meets Renesas in Japan on plans to expand Bengaluru R&D presence Read More »

Minister gifts grandson a Tesla, terms it green inspiration 

Maharashtra Transport Minister Pratap Sarnaik (right) with his new Tesla Maharashtra’s transport dreams are racing ahead at bullet speed — from Nitin Gadkari showcasing hydrogen-fuel cell cars and flash-charging buses in Nagpur, to futuristic aerial pods and hyperloop promises that could shrink the Mumbai-Pune journey to just 25 minutes. But the State’s latest headline stealer

Minister gifts grandson a Tesla, terms it green inspiration  Read More »

Court restrains reporters, activists from publishing defamatory content against Adani Enterprises

The injunction also restrained the defendants from making any further unverified or unsubstantiated statements about AEL and allowed the company to notify additional links for takedown. | Photo Credit: AMIT DAVE In a major relief to Adani Enterprises Limited (AEL), a Delhi court on Saturday restrained certain journalists and others from publishing unverified defamatory content

Court restrains reporters, activists from publishing defamatory content against Adani Enterprises Read More »

WHO expands Essential Medicines List to include diabetes, obesity treatments, cystic fibrosis and cancer drugs

This has been a long-standing demand from patient-families and treatment activists across the globe, including India. The World Health Organization’s model Essential Medicines List (EML) for adults and children has been expanded to include diabetes and anti-obesity treatments including GLP-1 receptor agonists (GLP-1 Ras) such as Ozempic and Mounjaro, cystic fibrosis medicine and new treatments

WHO expands Essential Medicines List to include diabetes, obesity treatments, cystic fibrosis and cancer drugs Read More »

Scroll to Top